Experiences and preferences in Zambia and South Africa for delivery of HIV treatment during a clients first six months: a cross-sectional survey
Mutanda, N.; Morgan, A.; Kamanga, A.; Sande, L.; Vntjikelane, V.; Maskew, M.; Haimbe, P.; Mulenga, P.; Rosen, S.; Scott, N.
Show abstract
BackgroundDisengagement from antiretroviral therapy (ART) is highest in the early treatment period ([≤]6 months after initiation/re-initiation), but low intensity models designed to increase retention generally exclude these clients. We describe client preferences for HIV service delivery in the early treatment period. MethodsFrom 9/2022-6/2023, we surveyed adult clients who were initiating or on ART for [≤]6 months at primary health facilities in South Africa and Zambia. We collected data on experiences with and preferences for HIV treatment. ResultsWe enrolled 1,098 participants in South Africa (72% female, median age 33) and 771 in Zambia (67% female, median age 32), 38% and 34% of whom were initiating/re-initiating ART in each country, respectively. While clients expressed varied preferences, most participants (94% in South Africa, 87% in Zambia) were not offered choices regarding service delivery. 82% of participants in South Africa and 36% in Zambia reported receiving a 1-month supply of medication at their most recent visit; however, South African participants preferred 2- or 3-month dispensing (69%), while Zambian participants preferred 3-or 6-month dispensing (85%). Many South African participants (65%) would prefer to collect medication in community settings, while Zambian participants (70%) preferred clinic-based collection. Half of participants desired more one-on-one counselling and health information. Most participants reported positive experiences with providers, but long waiting queues were reported by South African participants. ConclusionsDuring the first six months on ART, many clients would prefer less frequent clinic visits, longer dispensing intervals, and frequent, high-quality counselling. Care models for the early treatment period should reflect these preferences. RegistrationClinicaltrials.gov NCT05454839, Clinicaltrials.gov NCT05454852
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwes National Antiretroviral Therapy Programme between 2012 and 2015 97%
- Identifying Barriers to Disclosure to Overcome Barriers to ART Initiation: An explanatory qualitative study on PMTCT in Zambia 97%
- My family sold a cow to pay for my Traditional doctor and now there’s no money to travel to the HIV clinic : barriers to antiretroviral adherence among rural-Indigenous peoples living with HIV in the Comarca Ngäbe-Buglé, Panamá 97%
Similar papers in this journal
- Who does tracing work for? Characteristics of clients successfully re-engaged in ART care in sub-Saharan Africa after a tracing intervention: a systematic review 97%
- Effect of a brief psychological intervention for common mental disorders on HIV viral suppression: a non-randomised controlled study of the Friendship Bench in Zimbabwe 97%
- Integrating Isoniazid Preventive Therapy into the Fast-Track HIV Treatment Model in Urban Zambia: A Proof-of -Concept Pilot Project 96%
Similar papers in this journal
- The SENTINEL study of differentiated service delivery models for HIV treatment in Malawi, South Africa, and Zambia: research protocol for a prospective cohort study 96%
- Reduction in initiations of HIV treatment in South Africa during the COVID pandemic 96%
- Revisiting the use and effectiveness of patient-held records in rural Malawi 93%
Similar papers in this journal
- Symptoms of common mental disorders and adherence to antiretroviral therapy among adults living with HIV in rural Zimbabwe: a cross-sectional study 97%
- Cohort profile: the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2022 – cohort description, test volumes, predictors of viraemia, and the road ahead 96%
- Protocol for a qualitative study exploring the experiences and perceptions of dolutegravir/lamivudine dual antiretroviral therapy (the PEDAL Study) in people living with HIV 95%
Similar papers in this journal
- Postpartum continuity of care for women with HIV: Option B+ policy impact and limitations in South Africa 96%
- Disparities in access to Dolutegravir in West African children, adolescents and young adults aged 0-24 years living with HIV. A IeDEA Pediatric West African cohort analysis 96%
- Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.